Authors' reply

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6992.1470b (Published 03 June 1995) Cite this as: BMJ 1995;310:1470
  1. Anthony K Hall,
  2. D M Humphreys
  1. Medical adviser Medical director Boehringer Ingelheim, Bracknell, Berkshire RG12 8YS

    EDITOR,—We believe that the views expressed in our letter have been misinterpreted. This may have been because of the subtitle, “Benefits of thrombolysis were overstated,” which was chosen without consultation and is certainly not the message that we wished to impart. We firmly believe that thrombolysis is of considerable benefit in acute myocardial infarction. In addition, we recognise that earlier thrombolysis is important, but we consider that the relation between loss of benefit and time from the onset of symptoms to treatment is not …

    View Full Text

    Sign in

    Log in through your institution